Earnings, Fed Rates Mean Stocks Can Ignore the Shutdown. This Could Change That.
1. Novo Nordisk announced a major industry takeover, boosting biotech sector interest. 2. The takeover opens competition with Eli Lilly, positioning NVO advantageously. 3. Continued M&A activity may attract investors to biotech amid economic uncertainties. 4. Federal shutdown risks may affect overall market sentiment, impacting NVO indirectly. 5. Upcoming crucial earnings reports will provide insight into consumer health.